Skip to main content
Log in

Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome

  • Short Report
  • Published:
Journal of Inherited Metabolic Disease

Summary

Molecular defects in the gene encoding the enzyme iduronate-2-sulfatase (IDS) result in Hunter disease (mucopolysaccharidosis type II, MPS II). To determine the molecular basis of MPS II in Thailand, the IDS gene was analysed in 20 Thai patients with Hunter syndrome from 18 unrelated families. A total of 19 different mutations, including 9 missense mutations, 3 nonsense mutations, 3 splice site alterations, 1 deletion, 2 indels, and 1 rearrangement were identified, 8 of which were novel (p.R101C, p.D148V, p.G224A, p.K227E, p.E254X, p.W337X, c.440_442delinsTT and c.720_731delinsTTTCAGATGTTCTCCCCAG). Evaluation of the IDS activity of two hemizygous variants identified in the same patient, p.R101C and p.R468Q, by expression of IDS with the individual mutations in COS 7 cells indicated that only the p.R468Q mutation affected IDS protein activity. Two exonic mutations, c.257C>T (p.P86L) and c.418G>A, were found to activate multiple cryptic splice sites, resulting in aberrantly spliced transcripts. Thus, MPS II in Thailand is caused by a diverse set of defects affecting both IDS protein production and activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Abbreviations

ESE:

exonic splicing enhancer

IDS:

iduronate 2-sulfatase

IDS :

iduronate 2-sulfatase gene

IDS-2 :

iduronate 2-sulfatase pseudogene

References

  • Alves S, Mangas M, Prata MJ, et al (2006) Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations. J Inherit Metab Dis 29: 743–754.

    Article  PubMed  CAS  Google Scholar 

  • Bondeson ML, Malmgren H, Dahl N, Carlberg BM, Pettersson U. (1995a) Presence of an IDS-related locus (IDS2) in Xq28 complicates the mutational analysis of Hunter syndrome. Eur J Hum Genet 3: 219–227.

    PubMed  CAS  Google Scholar 

  • Bondeson ML, Dahl N, Malmgren H, et al (1995b) Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome. Hum Mol Genet 4: 615–621.

    Article  PubMed  CAS  Google Scholar 

  • Bunge S, Steglich C, Beck M, et al (1992) Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet 1: 335–339.

    Article  PubMed  CAS  Google Scholar 

  • Chang JH, Lin SP, Lin SC, et al (2005) Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II). Hum Genet 116: 160–166.

    Article  PubMed  CAS  Google Scholar 

  • Dou W, Peng C, Zheng JK, Gu XF (2007) Detection of two novel mutations of iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II. Hereditas (China) 29: 37–40.

    Article  CAS  Google Scholar 

  • Filocamo M, Bonuccelli G, Corsolini F, Mazzotti R, Cusano R, Gatti R (2001) Molecular analysis of 40 Italian patients with mucopolysaccharidosis type II: New mutations in the iduronate-2-sulfatase (IDS) gene. Hum Mutat 18: 164–165.

    Article  PubMed  CAS  Google Scholar 

  • Flomen RH, Green EP, Green PM, Bentley DR, Giannelli F (1993) Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene. Hum Mol Genet 2: 5–10.

    Article  PubMed  CAS  Google Scholar 

  • Froissart R, Maire I, Millat G, et al (1998) Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients. Clin Genet 53: 362–368.

    Article  PubMed  CAS  Google Scholar 

  • Hopwood JJ, Bunge S, Morris CP, et al (1993) Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene. Hum Mutat 2: 435–442.

    Article  PubMed  CAS  Google Scholar 

  • Isogai K, Sukegawa K, Tomatsu S, et al (1998) Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease). J Inherit Metab Dis 21: 60–70.

    Article  PubMed  CAS  Google Scholar 

  • Kato T, Kato Z, Kuratsubo I, et al (2005) Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II. J Hum Genet 50: 395–402.

    Article  PubMed  CAS  Google Scholar 

  • Kim CH, Hwang HZ, Song SM, et al (2003) Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: Identification of 13 novel mutations. Hum Mutat 21: 449–450.

    Article  PubMed  CAS  Google Scholar 

  • Lissens W, Seneca S, Liebaers I (1997) Molecular analysis in 23 Hunter disease families. J Inherit Metab Dis 20: 453–456.

    Article  PubMed  CAS  Google Scholar 

  • Lualdi S, Regis S, Di Rocco M, et al (2005) Characterization of iduronate-2-sulfatase gene-pseudogene recombinations in eight patients with mucopolysaccharidosis type II revealed by a rapid PCR-based method. Hum Mutat 25: 491–497.

    Article  PubMed  CAS  Google Scholar 

  • Lualdi S, Pittis MG, Regis S, et al (2006) Multiple cryptic splice sites can be activated by IDS point mutations generating misspliced transcripts. J Mol Med 84: 692–700.

    Article  PubMed  CAS  Google Scholar 

  • Millat G, Froissart R, Cudry S, Bonnet V, Maire I, Bozon D (1998) COS cell expression studies of P86L, P86R, P480L and P480Q Hunter’s disease-causing mutations. Biochim Biophys Acta 1406: 214–218.

    PubMed  CAS  Google Scholar 

  • Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3421–3452.

    Google Scholar 

  • Popowska E, Rathmann M, Tylki-Szymanska A, et al (1995) Mutations of the iduronate-2-sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mutat 5: 97–100.

    Article  PubMed  CAS  Google Scholar 

  • Rathmann M, Bunge S, Steglich C, Schwinger E, Gal A. (1995) Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28. Hum Genet 95: 34–38.

    Article  PubMed  CAS  Google Scholar 

  • Rathmann M, Bunge S, Beck M, Kresse H, Tylki-Szymanska A, Gal A (1996) Mucopolysaccharidosis type II (Hunter syndrome): mutation “hot spots” in the iduronate-2-sulfatase gene. Am J Hum Genet 59: 1202–1209.

    PubMed  CAS  Google Scholar 

  • Shapiro MB, Senapathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15: 7155–7174.

    Article  PubMed  CAS  Google Scholar 

  • Stenson PD, Ball EV, Mort M, et al (2003) Human gene mutation database (HGMD): 2003 udate. Hum Matat 21: 577–581.

    Article  CAS  Google Scholar 

  • Timms KM, Lu F, Shen Y, et al (1995) 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus. Genome Res 5: 71–78.

    Article  PubMed  CAS  Google Scholar 

  • Sukegawa K, Tomatsu S, Tamai K, et al (1992) Intermediate form of mucopolysaccharidosis type II (Hunter disease): a C1327 to T substitution in the iduronate sulfatase gene. Biochem Biophys Res Commun 183: 809–813.

    Article  PubMed  CAS  Google Scholar 

  • Sukegawa-Hayasaka K, Kato Z, Nakamura H, et al (2006) Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis. J Inherit Metab Dis 29: 755–761.

    Article  PubMed  CAS  Google Scholar 

  • Vafiadaki E, Cooper A, Heptinstall LE, Hatton CE, Thornley M, Wraith JE (1998) Mutation analysis in 57 unrelated patients with MPS II (Hunter’s disease). Arch Dis Child 79: 237–241.

    Article  PubMed  CAS  Google Scholar 

  • Voznyi YV, Keulemans JL, van Diggelen OP (2001) A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease). J Inherit Metab Dis 24: 675–680.

    Article  PubMed  CAS  Google Scholar 

  • Whitley CB, Anderson RA, Aronovich EL, et al (1993) Caveat to genotype–phenotype correlation in mucopolysaccharidosis type II: discordant clinical severity of R468W and R468Q mutations of the iduronate-2-sulfatase gene. Hum Mutat 2: 235–237.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors are grateful to the families of the patients for their assistance in this investigation and to the Chulabhorn Research Institute and Mahidol University for financial support. J.S. is a Senior Research Scholar of the Thailand Research Fund. D.W. and P.S. are recipients of Research Career Development Awards from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Svasti.

Additional information

Communicating editor: Douglas Brooks

Competing interests: None declared

References to electronic databases: Hunter syndrome: OMIM 309900. HUGO gene name: IDS. Iduronate-2-sulfatase (IDS): EC 3.1.6.13. Genbank accession number for IDS gene: AH002847.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keeratichamroen, S., Ketudat Cairns, J.R., Wattanasirichaigoon, D. et al. Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome. J Inherit Metab Dis 31 (Suppl 2), 303–311 (2008). https://doi.org/10.1007/s10545-008-0876-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-008-0876-z

Keywords

Navigation